Excipact ™ is a voluntary certification scheme aimed at companies that manufacture or distribute pharmaceutical excipients with a global outreach.
This certification scheme reinforces the safety of medication through a quality management system, whilst minimising quality assessment costs within the supply chain of excipients.
Good manufacturing practice (GMP) and good distribution practices (GDP) constitute the practical development of the concept of quality assurance and they are based on solid scientific criteria and risk assessments.
Applicable to manufacturers and distributors of pharmaceutical excipients.
Once the audit process has been successfully completed your organisation obtains:
BCN Trasvases, S.L. and Croda Iberica SA were the first companies to be certified by AENOR in this scheme.